Le Lézard
Classified in: Business
Subjects: MAV, FOR, POL, FVT, CFG

/R E P E A T -- Media Advisory - Technical briefing for media regarding irregular migration/


TORONTO, July 25, 2018 /CNW/ - Government officials from Immigration, Refugees and Citizenship Canada (IRCC) will be available to media to provide an update on irregular migration.

 

Date:

Thursday, July 26, 2018



Time:

2:00 p.m. (local time)



Location:

655 Bay Street, 3rd Floor Boardroom


Toronto, Ontario


M5G 2K4

                       

Notes for media:

This media technical briefing is for background information only, not for attribution.

 

SOURCE Immigration, Refugees and Citizenship Canada


These press releases may also interest you

at 05:30
BrightPoint (BP) LLC, an 8(a) joint venture between Buchanan & Edwards (BE) and i3, is pleased to announce its successful bid for a position on the U.S. Department of Commerce's Commerce Acquisition for Transformational Technology Services (CATTS)...

at 05:30
The "High Net Worth (Hnw) Asset Allocation Trends 2024" report has been added to  ResearchAndMarkets.com's offering. Drawing on our 2023 Global Wealth Managers Survey, this report analyzes HNW asset allocation strategies in 24 key markets. In...

at 05:30
FinVolution Group ("FinVolution," or the "Company") , a leading fintech platform, today announced that its Philippines financial application, Juanhand, has entered into a strategic cooperation agreement with SeaBank Philippines Bank ("SeaBank"), an...

at 05:20
Engel & Völkers Florida today announced the outstanding achievement of Michael Ledwitz, Broker/Owner of Engel & Völkers Boca Raton, who has been recognized as the Top Advisor in GCI for his outstanding performance in 2023. This prestigious accolade...

at 05:05
Building upon its recent success in revamping its indices product offering, leading CFD broker Vantage Markets ("Vantage") is thrilled to announce the introduction of enhanced website features and app enhancements, further solidifying its position as...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...



News published on and distributed by: